share_log

Theriva Biologics Shares Are Trading Lower. The Company Announced That the FDA Granted Rare Pediatric Drug Designation for VCN-01 for the Treatment of Retinoblastoma.

Benzinga ·  Jul 31 15:32
Theriva Biologics Shares Are Trading Lower. The Company Announced That the FDA Granted Rare Pediatric Drug Designation for VCN-01 for the Treatment of Retinoblastoma.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment